Zurcher Kantonalbank (Zurich Cantonalbank) Uro Gen Pharma Ltd. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

  • $32.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022
SELL
$5.12 - $8.74 $6,563 - $11,204
-1,282 Closed
0 $0
Q4 2019

Jan 21, 2020
SELL
$21.11 - $34.86 $24,044 - $39,705
-1,139 Reduced 47.05%
1,282 $43,000
Q1 2019

Apr 29, 2019
BUY
$35.47 - $54.55 $45,472 - $69,933
1,282 Added 112.55%
2,421 $89,000
Q2 2018

Aug 06, 2018
BUY
$48.35 - $65.33 $55,070 - $74,410
1,139 New
1,139 $57,000

Others Institutions Holding URGN

# of Institutions
129
Shares Held
35.9M
Call Options Held
22K
Put Options Held
93.8K
View Full List

About UroGen Pharma Ltd.

URGN Quotes by TradingView
  • Ticker URGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,740,500
  • Market Cap $234M
  • Description
  • UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...
More about URGN
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email